Norethindrone Acetate Dosing for Metrorrhagia
For acute management of metrorrhagia (irregular uterine bleeding), norethindrone acetate 5 mg orally twice daily for 10-14 days is the recommended starting dose, with the option to increase to 5 mg three times daily (15 mg total daily) if bleeding persists. 1
Dosing Regimens Based on Clinical Context
Acute Bleeding Control
- Initial dose: 5 mg orally twice daily (10 mg/day total)
- Duration: 10-14 days per cycle
- Titration: If bleeding continues, increase to 5 mg three times daily (15 mg/day maximum) 2
- Mechanism: Provides endometrial stabilization and hemostatic control
Chronic Management (Ovulatory Menorrhagia)
Important caveat: Norethindrone acetate at standard doses (5 mg twice daily on days 19-26) is not effective for ovulatory menorrhagia and may actually increase menstrual blood loss by 20% 3. For ovulatory heavy menstrual bleeding, tranexamic acid is superior, reducing blood loss by 45% 3.
Continuous Suppression Regimens
For patients requiring long-term bleeding suppression:
- Continuous daily dosing: 0.35 mg to 5 mg daily, depending on indication 1
- For endometrial protection with estrogen: 1 mg daily minimum in continuous regimens 2
- For complete amenorrhea: 5 mg daily has shown efficacy in suppressing bleeding associated with conditions like ACUM 4
Evidence-Based Treatment Algorithm
Step 1: Characterize the Bleeding Pattern
- Irregular/breakthrough bleeding (metrorrhagia): Use cyclic norethindrone acetate 5 mg twice daily for 10-14 days
- Regular heavy periods (ovulatory menorrhagia): Avoid norethindrone acetate; use tranexamic acid instead 3
- Prolonged bleeding on progestin contraception: Add norethindrone acetate 5 mg daily, which reduces bleeding frequency significantly within 2 weeks 5
Step 2: Dosing Strategy
- Start with 5 mg twice daily (10 mg/day) for acute control
- Continue for 10-14 consecutive days
- Expect bleeding cessation within 3-5 days of treatment initiation 6
- If inadequate response after 7 days, increase to 5 mg three times daily
Step 3: Maintenance Considerations
- Cyclic regimen: Repeat 5 mg twice daily for days 19-26 of each cycle for ongoing management 1
- Continuous suppression: Consider 5 mg daily for complete amenorrhea if cyclic bleeding is undesirable 4
- With estrogen therapy: Minimum 1 mg daily for endometrial protection in continuous regimens 2
Critical Clinical Pearls
When Norethindrone Acetate Works Best
- Anovulatory bleeding: Highly effective for stabilizing endometrium
- Breakthrough bleeding on progestins: Adding 5 mg daily reduces bleeding frequency by 38% compared to placebo 5
- Perimenopausal irregular bleeding: Effective for cycle regulation 7
When to Avoid or Use Alternatives
- Ovulatory menorrhagia: Norethindrone acetate at standard doses is ineffective and may worsen bleeding 3
- Acute hemorrhage requiring rapid control: Consider tranexamic acid 1 g four times daily instead 8, 3
- Contraindications: Women over 35 who smoke, history of thromboembolism 9
Monitoring and Adjustment
- Response timeline: Expect bleeding reduction within 2-7 days 6, 5
- Hemoglobin improvement: Monitor at 6 months; expect 1.9-2.3 g/dL increase with effective therapy 7, 10
- Treatment failure: If bleeding continues after 30 days of therapy, consider alternative diagnoses or surgical intervention 6
Safety Profile
- Generally well-tolerated with minimal side effects 7, 6, 5
- No increased risk of serious adverse events in short-term use (up to 6 months) 6, 5
- Controlled-release formulations show equivalent efficacy with potentially better adherence 7
Practical Prescribing
For immediate metrorrhagia control: Prescribe norethindrone acetate 5 mg tablets, take 1 tablet orally twice daily for 10-14 days. If bleeding persists after 7 days, increase to 1 tablet three times daily. Expect bleeding to stop within 3-5 days of starting treatment.
For recurrent episodes: After initial control, continue cyclic therapy with 5 mg twice daily on days 19-26 of each subsequent cycle, or transition to continuous 5 mg daily if amenorrhea is desired.